FDA Submission Update for Azelaic Acid by Taro Pharmaceuticals
Taro Pharmaceuticals has submitted an original application for Azelaic Acid under ANDA212581.
Company
Pharmaceutical intelligence for Taro Pharmaceuticals with 4 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
TARO's ANDA219052 for PERAMPANEL has received an approval status (AP) from the FDA.
No signals indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.